Global Pertussis Diagnostics Market Analysis and Forecast
The Global Pertussis Market Size is expected to grow from USD 4.51 billion in 2024 to USD 8.29 billion by 2035, at a CAGR of 6.28% during the forecast period 2025-2035
The global pertussis market refers to all activities involved in the development of vaccines, diagnostic tools, and methods of treatment for pertussis disease prevention and control. Pertussis is a highly contagious bacterial respiratory infection that infects a person when he or she is infected by the bacteria Bordetella pertussis and leads to severe coughing fits that threaten the health of infants and young children. The market experiences continuous development because vaccination rates worldwide increase, together with the establishment of stronger vaccination and disease monitoring systems.
This comprehensive market research report provides an in-depth analysis of the Pertussis market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global Pertussis Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR4675
Market Segmentation:
By Drug Class
- Biologics
- Calcineurin Inhibitors
- PDE-4 Inhibitor
- Corticosteroids
- Others
By Mode of Administration
- Topical
- Injectable
- Oral
Key Players Detail:
- Sanofi Pasteur
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Pfizer Inc.
- AstraZeneca
- Johnson & Johnson
- Novartis AG
- CSL Limited
- Takeda Pharmaceutical Company Limited
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Panacea Biotec Ltd.
In-depth competitive benchmarking analysis of the Pertussis Market, covering company market share, innovation strategies, product development, geographic expansion, and strategic partnerships shaping the industry landscape.
Key Insights Covered in the Global Pertussis Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global Pertussis Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of Pertussis Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth Pertussis Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Pertussis Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the Pertussis Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Pertussis Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR4675
Industry Developments:
In March 2026, with seven cases reported in early 2026, exceeding the previous year’s rate, the Guam Department of Public Health and Social Services organized a one-day vaccination clinic. It administered DTaP for children and Tdap for adults, including pregnant women, to control pertussis spread.
In February 2026, Australian whooping cough cases reached their highest level in 35 years, highlighting a significant surge. The disease proved particularly dangerous for babies, though it affected all age groups. Vaccination remained a key line of defence, emphasizing the importance of immunization in controlling outbreaks.
In December 2025, a new intranasal vaccine candidate, BPZE1, demonstrated encouraging results in reducing colonisation by Bordetella pertussis. Findings from a randomized Phase 2b trial at University Hospital Southampton and the University of Oxford confirmed its safety and efficacy in healthy adults aged 18–50 years.
Regional Analysis for Pertussis Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis.
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market.
Insightful inquiry before buying:- https://www.decisionsadvisors.com/request-customization/DAR4675
Frequently asked questions:
➥ What is the market size of the Pertussis market?
➥ What is the market growth rate of the Pertussis market?
➥ What are the Pertussis market opportunities and threats faced by the vendors in the global Pertussis Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Pertussis market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.decisionsadvisors.com/reports/pertussis-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
